Evidence map›Paper›PMID 37316134›Full record

ArticleAmerican journal of pharmaceutical education2023

Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs.

Molly A Nichols, Elizabeth G Riley, Alexander S Chao, Carmina G Sales, Monica L Miller, Geoffrey M Curran, Carol A Ott, Margie E Snyder, Karen Suchanek Hudmon

Open access · goldAbstract read
In one paragraph

Article in American journal of pharmaceutical education, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Molly A NicholsPurdue University College of Pharmacy, West Lafayette, IN, USA. Electronic address: magnew@purdue.edu.
Elizabeth G RileyPurdue University College of Pharmacy, West Lafayette, IN, USA.
Alexander S ChaoPurdue University College of Pharmacy, West Lafayette, IN, USA.
Carmina G SalesPurdue University College of Pharmacy, West Lafayette, IN, USA.
Monica L MillerPurdue University College of Pharmacy, West Lafayette, IN, USA.
Geoffrey M CurranUniversity of Arkansas for Medical Sciences College of Pharmacy, Little Rock, AR, USA.
Carol A OttPurdue University College of Pharmacy, West Lafayette, IN, USA.
Margie E SnyderPurdue University College of Pharmacy, West Lafayette, IN, USA.
Karen Suchanek HudmonPurdue University College of Pharmacy, West Lafayette, IN, USA.
Purdue University West Lafayette · USUniversity of Arkansas for Medical Sciences · US

Funding

AHRQ HHS F32 HS028749
6 · The paper itself

Abstract

objectivesTo characterize the instructional settings, delivery methods, and assessment methods of opioid use disorder (OUD) content in Doctor of Pharmacy (PharmD) programs; assess faculty perceptions of OUD content; and assess faculty perceptions of a shared OUD curriculum.

methodsThis national, cross-sectional, descriptive survey study was designed to characterize OUD content, faculty perceptions, and faculty and institutional demographics. A contact list was developed for accredited, US-based PharmD programs with publicly-accessible online faculty directories (n = 137). Recruitment and telephone survey administration occurred between August and December 2021. Descriptive statistics were computed for all items. Open-ended items were reviewed to identify common themes.

resultsA faculty member from 67 (48.9%) of 137 institutions contacted completed the survey. All programs incorporated OUD content into required coursework. Didactic lectures were the most common delivery method (98.5%). Programs delivered a median of 7.0 h (range, 1.5-33.0) of OUD content in required coursework, with 85.1% achieving the 4-hour minimum for substance use disorder-related content recommended by the American Association of Colleges of Pharmacy. Just over half (56.8%) of faculty agreed or strongly agreed that their students were adequately prepared to provide opioid interventions; however, 50.0% or fewer perceived topics such as prescription interventions, screening and assessment interventions, resource referral interventions, and stigma to be covered adequately. Almost all (97.0%) indicated moderate, high, or extremely high interest in a shared OUD curriculum.

conclusionEnhanced OUD education is needed in PharmD programs. A shared OUD curriculum was of interest to faculty and should be explored as a potentially viable solution for addressing this need.

Indexed as

Education, PharmacyOpioid-Related DisordersPharmacyAnalgesics, OpioidCross-Sectional StudiesHumansAnalgesics, OpioidCurriculumEducationOpioid use disorderPharmacy

Identifiers

PMID37316134
PMCPMC13270545
OpenAlexW4367153440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.